Persistent high prevalence of thyroid antibodies after immunosuppressive therapy in subjects with glomerulonephritis. A prospective three-year follow-up study

American Journal of Nephrology

Volumn 18, Issue 4, 1998, Pages 274-279

  Westman, Kerstin W A ^a,d   Bygren, Per G ^a   Ericsson, Ulla Britt ^a   Høier Madsen, Mimi ^b   Wieslander, Jörgen ^c   Erfurth, Eva Marie ^a  

^a Department of Nephrology ^*  (Sweden)

^b STATENS SERUM INSTITUT   (Denmark)

^c Wieslab AB   (Sweden)

^d LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Antineutrophil cytoplasmic antibodies; Glomerulonephritis; Thyroid antibodies; Thyroiditis

Indexed keywords

ANTINUCLEAR ANTIBODY; IMMUNOSUPPRESSIVE AGENT; NEUTROPHIL CYTOPLASMIC ANTIBODY; THYROGLOBULIN ANTIBODY; THYROID ANTIBODY; THYROID PEROXIDASE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; FEMALE; GLOMERULONEPHRITIS; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY;

EID: 0031801115     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000013350     Document Type: Article

References (33)

1. Weetman AP, Walport MJ: The association of autoimmune thyroiditis with systemic lupus erythematosus. Br J Rheumatol 1987;26:359-361.
2. Hansen BU, Ericsson UB, Larsson Å, Manthorpe R, Warfvinge G: Autoimme thyroiditis and primary Sjögren's syndrome: Clinical and laboratory evidence of the coexistence of the two diseases. Clin Exp Rheumatol 1991;9:137-141.
3. Landin-Olsson M, Karlsson A, Dahlquist G, et al: Islet cell and other organ-specific autoantibodies in all children developing type 1 (insulin-dependent) diabetes mellitus in Sweden during one year and in matched control children. Diabetologia 1989;32:387-395.
4. Westman KWA, Erfurth EMT, Hagmar L, Bygren PG, Ericsson U-B, Landin-Olsson M: Increased prevalence of thyroid peroxidase antibodies in women with glomerulonephritis. Nephrol Dial Transplant 1993;8:402-406.
5. Cahen R, François B, Trolliet P, Gilly J, Parchoux B: Aetiology of membranous glomerulonephritis: A prospective study of 82 adult patients. Nephrol Dial Transplant 1989;4:172-180.
6. Verger MF, Droz D, Vantelon J: Thyroid autoimmune diseases associated with glomerulonephritis (in French). Presse Méd 1983;12:83-86.
7. Wilson CB, Dixon FJ: The renal response to immunological injury; in Brenner BM, Rector FC Jr (eds): The Kidney, ed 3. Philadelphia, Saunders, 1986, vol 2, pp 838-940.
8. Rose NR: Pathogenic mechanisms in autoimmune diseases. Clin Immunol Immunopathol 1989;53:7-16.
9. Kallenberg CGM, Brouwer E, Weening JJ, Cohen Tervaert JW: Anti-neutrophil cytoplasmic antibodies: Current diagnostic and pathophysiological potential. Kidney Int 1994;46:1-15.
10. Van der Woude FJ, Lobatto S, Permin H, et al: Autoantibodies against neutrophils and monocytes: Tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet 1985;i:425-429.
11. Falk RJ, Jennette JC: Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescenting glomerulonephritis. N Engl J Med 1988;318: 1651-1657.
12. Koffler D, Agnello V, Thoburn R, Kunkel HG: Systemic lupus erythematosus: Prototype of immune complex nephritis in man. J Exp Med 1971;134:169-179s.
13. Jacob L, Viard J-P, Bach J-F: Recent advances in the pathogenesis of systemic lupus erythematosus; in Cameron S, Davison AM, Grünfeld J-P, Kerr D, Ritz E (eds): Oxford Textbook of Clinical Nephrology, ed 1. Oxford, Oxford University Press, 1992, vol 1, pp 636-645.
14. Bygren P, Rasmussen N, Isaksson B, Wieslander J: Anti-neutrophil cytoplasm antibodies. anti-GBM antibodies and anti-dsDNA antibodies in glomerulonephritis. Eur J Clin Invest 1992;22:783-792.
15. DeGroot LJ, Quintans J: The causes of autoimmune thyroid disease. Endocr Rev 1989;10: 537-562.
16. Weetman AP: Thyroid peroxidase as an antigen in autoimmune thyroiditis. Clin Exp Immunol 1990;80:1-3.
17. Steinberg AD, Kaltreider HB, Staples PJ, Goetzl EJ, Talal N, Decker JL: Cyclophosphamide in lupus nephritis: A controlled trial. Ann Intern Med 1971;75:165-171.
18. Peters DK, Rees AJ, Lockwood CM, Pusey CD: Treatment and prognosis in antibasement membrane antibody-mediated nephritis. Transplant Proc 1982;14:513-521.
19. Brun C, Olsen S: Atlas of Renal Biopsy, ed 1. Copenhagen, Munksgaard, 1981.
20. Jennette JC, Falk RJ, Andrassy K, et al: Nomenclature of systemic vasculitides: Proposal of an international consensus conference. Arthritis Rheum 1994;37:187-192.
21. Ericsson U-B, Larsson I, Murne A, Thorell I: A new sensitive immunosorbent radioassay for the detection of circulating antibodies to polypeptide hormones and proteins. Scand J Clin Lab Invest 1984;44:487-493.
22. Wiik A: Delineation of a standard procedure for indirect immunofluorescence detection of ANCA APMIS 1989;97(suppl 6):12-13.
23. Humbel RL: Detection of antinuclear antibodies by immunofluorescence; in Van Venrooij WJ, Maini RN (eds): Manual of Biological Markers of Disease. Dordrecht, Kluwer Academic Publishers, 1993, pp 1-16.
24. McGregor AM, Ibbertson HK, Smith BR, Hall R: Carbimazole and autoantibody synthesis in Hashimoto's thyroiditis. Br Med J 1980;281: 968-969.
25. Jansson R, Karlsson A, Dahlberg PA: Thyroxine, methimazole, and thyroid microsomal autoantibody titres in hypothyroid Hashimoto's disease. Br Med J 1985;290:11-12.
26. Tamura K, Woo J, Murase N, Carrieri G, Nalesnik M, Thomson A: Suppression of autoimmune thyroid disease by FK-506: Influence on thyroid infiltrating cells, adhesion molecule expression and anti-thyroglobulin antibody production. Clin Exp Immunol 1993;91:368-375.
27. Weetman AP, Pinching AJ, Pussel BA, Evans DJ, Sweny P, Rees AJ: Membranous glomerulonephritis and autoimmune thyroiditis (letter to the editor). Clin Nephrol 1981;15:50-51.
28. Masor JJ, Gal AA, LiVolsi VA: Case report: Hashimoto's thyroiditis associated with Wegener's granulomatosis. Am J Med Sci 1994; 308:112-114.
29. Cohen Tervaert JW, Huitema MG, Hené RJ, et al: Prevention of relapses in Wegener's granulomatosis by treatment on antineutrophil cytoplasmatic antibody titre. Lancet 1990;336: 709-711.
30. Couchman KG, Wigley RD, Prior IAM: Autoantibodies in the Carterton population survey. The prevalence of thyroid and gastric antibodies, antinuclear and rheumatoid factors, in a probability-based population sample. J Chronic Dis 1970;23:45-53.
31. Bosch X, Mirapeix E, Font J, et al: Prognostic implication of anti-neutrophil cytoplasmic autoantibodies with myeloperoxidase specificity in anti-glomerular basement membrane disease. Clin Nephrol 1991;36:107-113.
32. Pusey CD, Bowman C, Morgan A, Weetman AP, Hartley B, Lockwood CM: Kinetics and pathogenicity of autoantibodies induced by mercuric chloride in the brown Norway rat. Clin Exp Immunol 1990;81:76-82.
33. Avrameas S, Ternynck T: The natural autoantibodies system: Between hypotheses and facts Mol Immunol 1993;30:1133-1142.